Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 2Head & Neck 2Gynecologic 2Genitourinary 2Gastrointestinal 2Endocrine 2CNS 2Thoracic 1Sarcoma 1Other hematologic neoplasm 1Dermatologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Thymus Neoplasms 1Testicular Neoplasms 1Skin Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Unknown Primary 1Hematologic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Adrenal Gland Neoplasms 1

Interventions

pertuzumab 2aflibercept 2Trastuzumab 2Polymerase Chain Reaction 2Nicotine 2Magnetic Resonance Spectroscopy 2Gene Expression Profiling 2Counseling 2Bupropion 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tanespimycin 1sapanisertib 1romidepsin 1relatlimab 1pembrolizumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1erdafitinib 1entinostat 1defactinib 1dabrafenib 1copanlisib 1cc-486 1capivasertib 1binimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × FAPI-46 × Other hematologic neoplasm × Clear all
NCT04459273 2026-02-05

FAPI PET RDRC

Jonsson Comprehensive Cancer Center

Phase 1 Active not recruiting
26 enrolled
CNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETOther hematologic neoplasm

Adrenal Gland Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Unknown Primary, Skin Neoplasms, Testicular Neoplasms, Thymus Neoplasms, Thyroid Neoplasms, Cholangiocarcinoma, Neuroendocrine Tumors, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡